Recombinant HDL (Milano) protects endotoxin-challenged rats from multiple organ injury and dysfunction.

Abstract

Endotoxemia, the systemic inflammatory host response to infection, leads to severe septic shock and multiple organ injury and dysfunction syndrome (MOPS), which cause mortality. Apolipoprotein A-IMilano (apoAIM), a naturally occurring cysteine mutant of apoAI with dimers as its effective form, showed an enhanced cardiovascular protective activity compared with wild-type apoAI (apoAIwt). To investigate the role of recombinant high-density lipoprotein (rHDL) reconstituted with apoAIM (rHDLM) on endotoxemia and MOPS, we examined the anti-inflammatory, anti-oxidant, and protective effects of this cysteine mutant against organ injury in endotoxin-challenged rat models compared with rHDLwt. In the present study, we demonstrated for the first time that pretreatment with rHDLM significantly attenuated liver and renal dysfunction and histopathological features of lung injury in endotoxin-challenged endotoxemia rats. Administration of rHDLM to endotoxemia rats dramatically suppressed proinflammatory cytokines and adhesion molecule increase in tumor necrosis factor α, interleukin 1β, interleukin 6, and intercellular adhesion molecule 1. In addition, rHDLM pretreatment inhibited lipid peroxidation and enhanced total antioxidant capacity in vivo. In comparison with rHDLwt, rHDLM showed enhanced capacity on anti-inflammatory and anti-oxidant functions. In summary, administration of rHDLM protected endotoxin-challenged endotoxemia and MOPS through enhanced anti-inflammatory and anti-oxidant properties.

• Authors: Xinbo Zhang, Luya Wang, Baosheng Chen
• Journal: Biological chemistry (Biol Chem) Vol. 396 Issue 1 Pg. 53-60 (Jan 2015) ISSN: 1437-4315 [Electronic] Germany
• PMID: 25205725 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Anti-Inflammatory Agents
• Apolipoprotein A-I
• Endotoxins

Topics

• Animals
• Anti-Inflammatory Agents (administration & dosage)
• Apolipoprotein A-I (administration & dosage)
• Endotoxemia (complications)
• Endotoxins
• Multiple Organ Failure (drug therapy)
• Rats